BiOkuris

BiOkuris develops next-generation medical nutrition products tailored to unmet medical needs of patients with chronic intestinal diseases such as IBS, IBD, and Candidiasis. The company's solutions are designed to improve physiopathology and quality of life for patients with these conditions. The company announced positive results from a pivotal IBS study evaluating BK002.